✦ LIBER ✦

Population pharmacokinetic/pharmacodynamic modelling of the anti-TNF-αpolyclonal fragment antibody AZD9773 in patients with severe sepsis

✍ Scribed by James W. T. Yates, Shampa Das, Guy Mainwaring, John Kemp

Book ID: 118803322
Publisher: Springer
Year: 2012
Tongue: English
Weight: 463 KB
Volume: 39
Category: Article
ISSN: 1573-8744
DOI: 10.1007/s10928-012-9270-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Phase II study of polyclonal anti-TNF-

A Phase II study of polyclonal anti-TNF-α (AZD9773) in Japanese patients with severe sepsis and/or septic shock

✍ Naoki Aikawa,Takeshi Takahashi,Satoshi Fujimi… 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 108 KB

A placebo-controlled, double-blind, dose

A placebo-controlled, double-blind, dose-escalation study to assess the safety, tolerability and pharmacokinetics/pharmacodynamics of single and multiple intravenous infusions of AZD9773 in patients with severe sepsis and septic shock

✍ Peter E Morris; Brian Zeno; Andrew C Bernard; Xiangning Huang; Shampa Das; Timi 📂 Article 📅 2012 🏛 Springer (Biomed Central Ltd.) 🌐 English ⚖ 300 KB

A multicenter, open-label, prospective,

A multicenter, open-label, prospective, randomized, dose-ranging pharmacokinetic study of the anti-TNF-α antibody afelimomab in patients with sepsis syndrome

✍ James Gallagher; Charles Fisher; Bruce Sherman; Mark Munger; Bruce Meyers; Travi 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 133 KB